Tool Sprawl Risk Audit — Clinical Trials Operations

Find out how much spreadsheet and SaaS sprawl is costing Clinical Trials Operations — and where a purpose-built internal tool pays off.

Signs of tool sprawl in Clinical Trials Operations

Patient recruitment is the single biggest cause of trial delay; sites enroll well below plan and the sponsor cost-of-delay runs into seven-figures-per-day on Phase III studies.
Protocol amendments are frequent, expensive, and operationally disruptive — every amendment ripples through CTMS, EDC, eConsent, and site training.
Regulatory and quality discipline (GCP, ICH, 21 CFR Part 11, EU CTR) is non-negotiable and the audit-and-evidence workflow is sustained.
Site activation cycles are long; the time from contract-and-budget execution to first-patient-in is the operational bottleneck nobody loves.

Section 1 of 4 · Source of Truth0/8 answered

Source of Truth

Whether your operational data lives in one place or is scattered across tools.

1.Where does your core operational data live?

2.How many tools/spreadsheets hold 'the truth' for one workflow?

Send us the result and the constraint behind it. We’ll scope the diagnostic, sprint, or build that fixes what the score reveals.